Bright Minds Biosciences Ratios (2020-2026) | DRUG

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter)
14.07M10.76M8.10M8.09M8.89M7.95M6.84M5.71M5.10M4.95M4.72M4.53M23.14M40.58M38.62M49.62M63.26M144.56M
Equity Average (Quarter)
13.63M10.17M7.55M7.35M8.08M7.35M6.18M5.34M15.33M25.88M15.23M15.21M44.85M51.29M51.87M62.25M61.82M178.14M
Invested Capital (Quarter)
15.41M11.84M8.49M6.62M8.08M8.08M6.62M5.75M4.98M25.70M26.01M4.46M26.03M63.78M38.79M64.83M59.62M63.96M266.73M
Leverage & Solvency
Debt to Equity (Quarter)
0.010.000.000.000.000.000.00
Equity Ratio (Quarter)
0.970.970.910.960.870.950.900.910.965.095.370.975.801.520.991.710.970.98
Debt Ratio (Quarter)
0.01-0.010.010.000.000.000.00
Valuation
Enterprise Value (Quarter)
-0.65M-15.70M-15.68M-15.60M-15.50M-8.92M-8.63M-8.67M-8.72M-5.09M-4.96M-5.03M-4.94M-4.26M-4.17M-38.88M-4.20M-60.31M-59.53M
Return Ratios
Return on Capital Employed (Quarter)
-9.35%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%